|
SMARCE1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.071610E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.356960E-01 |
| Normal-vs-Stage2 |
5.023800E-02 |
| Normal-vs-Stage3 |
2.008700E-04 |
| Normal-vs-Stage4 |
8.576200E-03 |
| Stage1-vs-Stage2 |
2.574600E-01 |
| Stage1-vs-Stage3 |
3.942000E-03 |
| Stage1-vs-Stage4 |
1.400760E-01 |
| Stage2-vs-Stage3 |
4.335000E-01 |
| Stage2-vs-Stage4 |
9.570600E-01 |
| Stage3-vs-Stage4 |
3.179600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.564600E-03 |
| Normal-vs-AfricanAmerican |
4.848300E-02 |
| Normal-vs-Asian |
6.611400E-01 |
| Caucasian-vs-AfricanAmerican |
7.610800E-01 |
| Caucasian-vs-Asian |
1.756980E-01 |
| AfricanAmerican-vs-Asian |
2.394800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.497900E-03 |
| Normal-vs-Female |
1.770810E-01 |
| Male-vs-Female |
1.202100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.553000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.502000E-02 |
| Normal-vs-Age(61-80Yrs) |
4.080700E-03 |
| Normal-vs-Age(81-100Yrs) |
2.396600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.439800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.382600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.196220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.713600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.108400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.322780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.851600E-01 |
| Normal-vs-Grade 2 |
3.836000E-01 |
| Normal-vs-Grade 3 |
4.44390000000627E-05 |
| Normal-vs-Grade 4 |
2.038100E-04 |
| Grade 1-vs-Grade 2 |
1.137580E-01 |
| Grade 1-vs-Grade 3 |
5.210700E-04 |
| Grade 1-vs-Grade 4 |
8.630900E-04 |
| Grade 2-vs-Grade 3 |
5.66419999999956E-05 |
| Grade 2-vs-Grade 4 |
4.444900E-04 |
| Grade 3-vs-Grade 4 |
6.253800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.070200E-01 |
| Normal-vs-ccB subtype |
1.236730E-03 |
| ccA subtype-vs-ccB subtype |
1.104330E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.066040E-02 |
| Normal-vs-N1 |
8.783000E-01 |
| N0-vs-N1 |
2.551800E-01 |
|
|
